Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model

by Wilson MR, Patel JG, Coleman A, McDade CL, Stanford RH, Earnshaw SR
Published 2017-03-01

Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China

by Mao NY, Lesher B, Liu QF, Qin L, Chen YX, Gao X, Earnshaw SR, McDade CL, Charbonneau C
Published 2016-06-01